Economic Evaluation of Subcutaneous Methotrexate For Long-Term Treatment of Moderate-To-Severe Psoriasis In The United Kingdom

Full Text

Cost-effectiveness of Rituximab versus Calcineurin inhibitors for refractory Myasthenia Gravis

M. Georgieva S. Wheeler J.F. Howard Jr.

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now